NANOVIRICIDES, INC. Convertible Preferred Stock, Shares Issued upon Conversion
NANOVIRICIDES, INC. (NNVC) had Convertible Preferred Stock, Shares Issued upon Conversion of 3.5 shares as of 2020-03-31, per its 10-Q filed 2020-06-22.
Discontinued › Notes › Equity › Stockholders' Equity Note › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2020-06-22
- 2020-03-31: Convertible Preferred Stock, Shares Issued upon Conversion 3.50 shares.
- 2019-12-31: Convertible Preferred Stock, Shares Issued upon Conversion 3.50 shares.
- 2019-09-30: Convertible Preferred Stock, Shares Issued upon Conversion 3.50 shares.
- 2013-09-30: Convertible Preferred Stock, Shares Issued upon Conversion 1.13M shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion |
|---|---|
| 2020-03-31 | 3.50 shares 10-Q · filed 2020-06-22 |
| 2019-12-31 | 3.50 shares 10-Q · filed 2020-02-14 |
| 2019-09-30 | 3.50 shares 10-Q · filed 2019-11-15 |
| 2013-09-30 | 1.13M shares 10-Q/A · filed 2013-11-18 |
| 2013-06-30 | 1.20M shares 10-K/A · filed 2013-10-08 |
| 2012-06-30 | 4.78M shares 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |